Skip to content

Comparison of the effect of oral Oxycodone versus intravenous Ketorolac on post laparoscopic cholecystectomy pain

Comparison of the effect of oral Oxycodone versus intravenous Ketorolac on post laparoscopic cholecystectomy pain

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181216041991N1
Enrollment
60
Registered
2019-01-23
Start date
2019-01-10
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The effect of medications on post laparoscopic cholecystectomy pain.

Interventions

Intervention 1: Intervention group: In the first group patients receive 30 mg of oral oxycodone before anesthesia induction. Intervention 2: Intervention group: In the second group before anesthesia i

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients candidate for laparoscopic cholecystectomy Age between 18-65 year

Exclusion criteria

Exclusion criteria: No history of drug abuse No history of psychologic disease No allergy to studied drugs No pregnancy and lactation No clinical sign due to sepsis or other inflammatory disease No history of liver and renal failure No history of GI bleeding No history of coagulopathies No history of sign of neuropathy No diagnosis of gangrenous cholecystitis No diagnosis of generalized peritonitis

Design outcomes

Primary

MeasureTime frame
Postoperative pain. Timepoint: 1,2,4,6,12 hours postoperative. Method of measurement: Numerical rating Scale;The NRS is a 10 cm horizontal bar which is divided to 0-10 pieces. Respondent selects a whole number (0–10 integers) that best reflects the intensity of his/her pain. Number zero eqauals no pain, while number ten means unbearable pain.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoud Nashibi

Shahid Beheshti University of Medical Sciences

masoudnashibi@sbmu.ac.ir+98 21 5542 4040

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026